Our Team

Vitalief Leadership Team

David Moore

Chief Executive Officer and Chairman of the Board

David is an accomplished business leader and serial entrepreneur with a proven track record of building and growing successful organizations. He has served in various roles, including senior executive, entrepreneur, angel investor, Board Member, and advisor for numerous corporate and non-profit organizations. David has led and advised a diverse collection of companies where he has prioritized people and inspired teams to meet their individual and collective goals. David has employed his passion for people to engage and encourage team members in software, service, consulting, and technology start-ups.
As CEO, David challenges the Vitalief team to think differently about the emerging resource issues in clinical trials to create and deliver future-ready solutions.

Judy Mimeault

Chief Operating Officer

Judy is a transformational executive with a strong history of building organizations from the ground up. Her 30+-year career in operations spans several different vertical sectors, from IT services organizations to learning and development and sales performance solutions.
As a C-level advisor, Judy has helped companies structure their organizations for growth while creating a culture of innovation. Judy focuses on actualizing valuable ideas and employing innovative strategies that maximize organizational capabilities, operations, service offerings, and employee performance.
At Vitalief, Judy is envisioning and implementing an operational model that addresses the seemingly conflicting needs for practical expertise and unprecedented flexibility in today’s clinical trial workforce.

Glenn Murani

Director of Talent Acquisition

Glenn is an accomplished Talent Acquisition professional with over 20 years of experience in driving high-growth, startup, and mid-sized professional services consulting firms to attract and retain top talent. His career track record includes hiring nearly 1,000 professionals across the Life Sciences, Healthcare, and Financial Services industries. Glenn is also passionate about coaching and mentoring individuals in transition and has conducted numerous Career Transition Workshops for outplacement firms.
In his role as Director of Talent Acquisition, Glenn identifies and recruits clinical trial professionals who are passionate about their work, excited to be part of a PEOPLE-FIRST culture and want to improve the lives of patients in need of new therapies.

Dave Granese

Chief Financial Officer

Dave is a driven, results-oriented financial executive with multi-industry experience in strategic planning, growth, and expansion. He brings a wealth of expertise in global financial operations within the CRO and professional services industries to his role. He has extensive practical experience managing and executing successful M&A and other growth strategies. Dave has spent over 20 years establishing a well-earned reputation for finance and operational leadership. As a skilled and dedicated leader, he is comfortable guiding, educating, and collaborating with stakeholders to achieve shared goals. At Vitalief, he leads financial activities including accounting, mergers and acquisitions, financial planning, analysis, forecasting, and risk management.

Board of Directors

John Doll

COO of RWJBarnabas Health

John Doll was named Chief Operating Officer of RWJBarnabas Health in March 2022. In this role, he oversees the day-to-day operations of the health system – including all hospital and Medical Group operations, as well as finance, information technology, human resources, quality, and legal affairs functions. Prior to his promotion and for over a decade, Mr. Doll guided RWJBarnabas Health’s financial operations through mergers, consolidations, and health crises in such leadership roles as Chief Integration Officer, Chief Financial Officer and, as of 2020, Chief Financial and Administrative Officer.
As leader of the RWJBH Strategic Council, he guides fellow c-suite leaders in sharing best practices and priorities, ensuring that the System’s resources are appropriately dedicated in achieving the organization’s mission. Prior to joining Barnabas Health in 2010, Mr. Doll held executive positions at a large regional health system and a healthcare information technology and consulting firm. He began his career in Ernst & Young’s Healthcare Audit and Consulting practice. 

Mark Kolb

Entrepreneur in Residence at Tech Council Ventures

Mark Kolb is the Entrepreneur in Residence at Tech Council Ventures. He has broad experience in healthcare, life sciences, and IT industries. Mark currently chairs the board of Dorsata and serves on the Optima Global Solutions Advisory Board and the NJEDA Technology Advisory Board. He previously served as CEO of Bergen Medical Products, CEO of BK Health, and Chairman of the Board and CEO at Dynamic Clinical Systems. Earlier he founded the life sciences consulting firm Taratec Development Corporation and sold the company to Patni Computer Systems, one of India’s largest IT firms.

Steven K. Libutti, MD, FACS

Director of Rutgers Cancer Institute of New Jersey and Vice-Chancellor for Cancer Programs

Steven K. Libutti, MD, FACS, is the Director of Rutgers Cancer Institute of New Jersey and Vice Chancellor for Cancer Programs, Rutgers Biomedical and Health Sciences. Dr. Libutti also serves as Senior Vice President of Oncology Services for RWJBarnabas Health, Professor of Surgery at Rutgers Robert Wood Johnson Medical School, and an Affiliated Distinguished Professor in Genetics at the Rutgers School of Arts and Sciences Department of Genetics. He served as President of the American Association of Endocrine Surgeons and is the recipient of funding from the National Cancer Institute (NCI) for the past 20 years.

Reynold A. Panettieri, Jr., MD

inaugural Director of the Institute for Translational Medicine and Science and Vice Chancellor for Translational Medicine and Science at Rutgers University

Reynold A. Panettieri, Jr, MD, is the inaugural Director of the Institute for Translational Medicine and Science and Vice Chancellor for Translational Medicine and Science at Rutgers University. He is also the Robert Wood Johnson Medical School and Emeritus Professor of Medicine at the University of Pennsylvania. He previously served as the Director of the Airways Biology Initiative at the University of Pennsylvania and as chairperson of the NIH Lung Cellular, Molecular, and Immunobiology Study Section. He is a member of the NIH Distinguished Editorial Panel and is a member of the American Society for Clinical Investigation and the Association of American Physicians.

David Moore

Chief Executive Officer and Chairman of the Board

David is an accomplished business leader and serial entrepreneur with a proven track record of building and growing successful organizations. He has served in various roles, including senior executive, entrepreneur, angel investor, Board Member, and advisor for numerous corporate and non-profit organizations. David has led and advised a diverse collection of companies where he has prioritized people and inspired teams to meet their individual and collective goals. David has employed his passion for people to engage and encourage team members in software, service, consulting, and technology start-ups.
As CEO, David challenges the Vitalief team to think differently about the emerging resource issues in clinical trials to create and deliver future-ready solutions.